PALISADE BIO, INC. — Director's Dealing 2013

Apr 26, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2012-12-31

Reporting Person: WESTREICH STANLEY (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-03	Restricted Stock Unit	$	A	30702	Acquired		Common Stock (30702)	Direct
2012-04-01	Common Stock Purchase Option	$1.12	A	35000	Acquired	2019-04-01	Common Stock (35000)	Direct

Footnotes

F1: Represents Restricted Stock Units issued in lieu of cash compensation for director services. The restricted stock units vest quarterly of the year commencing on 4/3/2012.

F2: Represents compensatory Annual Grant and Committee Grants for Director Services. The options vest quarterly over the year commencing on 4/1/2012.

F3: N/A